INIS
messenger-rna
100%
antibodies
100%
workers
100%
levels
75%
covid-19
75%
risks
50%
sex
50%
indonesia
25%
obesity
25%
hospitals
25%
mortality
25%
blood
25%
vaccines
25%
diabetes mellitus
25%
hypertension
25%
morbidity
25%
Keyphrases
Healthcare Workers
100%
Booster Vaccination
100%
SARS-CoV-2 Infection
100%
MRNA-1273
100%
Antibody Level
42%
Comorbidity
28%
Adverse Events Following Immunization
28%
Indonesia
14%
Obesity-related Hypertension
14%
Risk Reduction
14%
Vaccination
14%
Incidence Rate
14%
Diabetes Mellitus Type 2
14%
Blood Samples
14%
Preventive Measures
14%
Relative Risk
14%
Antibody Profile
14%
Tertiary Hospital
14%
Retrospective Cohort
14%
COVID-19 Pandemic
14%
COVID-19 Incidence
14%
CoronaVac
14%
Vaccination History
14%
COVID-19 Vaccination
14%
Booster Vaccine
14%
Primary Vaccination
14%
Medicine and Dentistry
Infection
100%
Health Care
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Messenger RNA
100%
Adverse Event
28%
COVID-19
28%
Comorbidity
28%
Cross Sectional Study
14%
Maturity Onset Diabetes of the Young
14%
COVID-19 Vaccination
14%
Booster Dose
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
SARS Coronavirus
100%
Messenger RNA
100%
Adverse Event
28%
Comorbidity
28%
Cross-Sectional Study
14%
Pandemic
14%
Non Insulin Dependent Diabetes Mellitus
14%